First FASEB conference in Africa-The 2023 FASEB conference on Imaging Cellular and Chromosome Dynamics held on August 27-30, 2023 in Accra, Ghana.

Access to scientific meetings and conferences is limited in low- and middle-income countries (LMIC). Efforts are being implemented to rectify this issue through short workshops, seminars, and conferences. Sena Institute of Technology (SIT), a nonprofit research institute based in Ghana, is one such organization championing this initiative. Through a partnership with the Federation of American Societies for Experimental Biology (FASEB), SIT hosted the first FASEB conference in Africa from August 27-30, 2023 in Ghana. The 3-day conference brought together scientists specialized in imaging, genetics, and cell biology from across the globe to discuss the theme "Imaging Cellular and Chromosome Dynamics." The Ghanaian Ministry of Environment, Science, Technology and Innovation (MESTI) and the Ghana Tourism Authority (GTA) provided local support to the meeting. At the end of the conference, participants recommended continuing engagement and the organization of more such meetings on the African continent.

Uterine fibroids - Causes, impact, treatment, and lens to the African perspective.

Leiomyomas, or uterine fibroids as they are commonly known, are mostly seen in women of reproductive age. However, they can go undetected in most women, and approximately 25% of women show clinical symptoms. Although fibroids are a global burden impacting 80% of premenopausal women, they are more prevalent among Black women than among women of other races. Based on clinical diagnosis, the estimated cumulative incidence of fibroids in women ≤50 years old is significantly higher for black (>80%) versus white women (∼70%). The cause of leiomyomas is not clearly known, but studies have shown evidence of factors that drive the development or exacerbation of the disease. Evidence has linked risk factors such as lifestyle, age, environment, family history of uterine fibroids, and vitamin D deficiencies to an increased risk of uterine fibroids, which impact women of African descent at higher rates. Treatments may be invasive, such as hysterectomy and myomectomy, or non-invasive, such as hormonal or non-hormonal therapies. These treatments are costly and tend to burden women who have the disease. Sub-Saharan Africa is known to have the largest population of black women, yet the majority of uterine fibroid studies do not include populations from the continent. Furthermore, the prevalence of the disease on the continent is not well determined. To effectively treat the disease, its drivers need to be understood, especially with regard to racial preferences. This paper aims to review the existing literature and build a case for conducting future research on African women.